What is Xenon Pharmaceuticals's net investment in lease?

Xenon Pharmaceuticals (XENE) reported net investment in lease of $6.29M in Q1 2026.

How has Xenon Pharmaceuticals's net investment in lease changed year-over-year?

Xenon Pharmaceuticals's net investment in lease decreased by 17.4% year-over-year, from $7.62M to $6.29M.

What is the long-term trend for Xenon Pharmaceuticals's net investment in lease?

Over 5 years (2020 to 2025), Xenon Pharmaceuticals's net investment in lease has grown at a 14.8% compound annual growth rate (CAGR), from $3.33M to $6.63M.

Xenon Pharmaceuticals XENE Net Investment in Lease

Net Investment in Lease at other companies

Jazz PharmaceuticalsJAZZ

——

Axsome TherapeuticsAXSM

——

Praxis Precision Medicines, Inc.PRAX

——

Neurocrine BiosciencesNBIX

——

BridgeBio PharmaBBIO

——

Roivant SciencesROIV

——

Other financials

Income statement

See full

Revenue--100%

Operating income-$112.3M-54.4%

Net income-$102.3M-57.3%

EPS (diluted)-$1.17-41.0%

Balance sheet

See full

Cash & equivalents$545.9M+368%

Total debt$7.5M-13.6%

Total equity$1.3B+90.0%

Total assets$1.4B+86.6%

Cash flow

See full

Operating cash flow-$88.9M-44.2%

CapEx$133.0K+209%

Free cash flow-$89.0M-44.3%

Valuation

See full

Market cap$5.11B+116%

Profitability

See full

Operating margin-4,974.3%—

Net margin-4,612.1%—

FCF margin-3,732.2%—

Returns & leverage

See full

Return on equity-37.5%+8.7pp

Debt / equity0×0.0×

Current ratio27.8×+10.1×

Where this comes from

Reported directly by Xenon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xenon Pharmaceuticals's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xenon Pharmaceuticals's net investment in lease?: Xenon Pharmaceuticals (XENE) reported net investment in lease of $6.29M in Q1 2026.
How has Xenon Pharmaceuticals's net investment in lease changed year-over-year?: Xenon Pharmaceuticals's net investment in lease decreased by 17.4% year-over-year, from $7.62M to $6.29M.
What is the long-term trend for Xenon Pharmaceuticals's net investment in lease?: Over 5 years (2020 to 2025), Xenon Pharmaceuticals's net investment in lease has grown at a 14.8% compound annual growth rate (CAGR), from $3.33M to $6.63M.